UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
UNITED THERAPEUTICS Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$543.15+10.03 (+1.88%)
Close on Oct 19, 2026
- Market cap
- $24.88B
- P/E (TTM)
- 19.4
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
97.4%
42M of 43M shares
Institutional holders
878
107 new, 70 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
1 buys · 2487 sales
Net sold $1.35B
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 5,294,844 | 11.30% | 13G (passive) amendment | Dec 31, 2023 |
| Behzad Aghazadeh | 2,858,888 | 6.10% | 13G (passive) amendment | Dec 31, 2023 |
| Wellington Investment Advisors Holdings LLP | 2,463,891 | 5.50% | 13G (passive) amendment | Dec 31, 2024 |
| Wellington Group Holdings LLP | 2,441,492 | 5.70% | 13G (passive) | Dec 31, 2025 |
| Rothblatt Martine A | 2,333,721 | 5.30% | 13G (passive) amendment | Jun 30, 2026 |
| Vanguard Capital Management | 2,278,348 | 5.19% | 13G (passive) | Mar 31, 2026 |
| United Therapeutics Corporation | 1 | 100.00% | 13D (active) | Dec 12, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of UTHR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,294,529 | 12.34% | $2.87B | −105,120 | 0.04% |
| Avoro Capital Advisors LLC | 2,777,777 | 6.48% | $1.51B | +147,777 | 13.52% |
| Vanguard Portfolio Management LLC | 1,919,429 | 4.48% | $1.04B | −84,313 | 0.05% |
| Vanguard Capital Management LLC | 1,918,256 | 4.47% | $1.04B | −39,283 | 0.02% |
| State Street Corp | 1,898,064 | 4.43% | $1.03B | +54,101 | 0.03% |
| Renaissance Technologies LLC | 1,708,739 | 3.98% | $925.85M | −78,280 | 1.27% |
| Wellington Management Group Llp | 1,379,025 | 3.22% | $747.20M | −885,222 | 0.13% |
| Geode Capital Management, LLC | 996,598 | 2.32% | $538.86M | −236,431 | 0.03% |
| Jupiter Topco LLC | 831,129 | 1.94% | $450.14M | New | 0.18% |
| Norges Bank | 694,753 | 1.62% | $376.44M | New | 0.04% |
| Assetmark, Inc | 624,068 | 1.46% | $338.14M | +8,018 | 0.58% |
| Aqr Capital Management LLC | 546,002 | 1.27% | $294.64M | −280,224 | 0.10% |
| Dimensional Fund Advisors LP | 527,904 | 1.23% | $286.05M | +15,165 | 0.05% |
| FMR LLC | 473,409 | 1.10% | $256.51M | −54,937 | 0.01% |
| Invesco Ltd. | 473,109 | 1.10% | $256.34M | −135,258 | 0.02% |
| Baillie Gifford & Co | 467,209 | 1.09% | $253.15M | +39,082 | 0.23% |
| Deerfield Management Company, L.P. (Series C) | 457,000 | 1.07% | $247.62M | – | 2.58% |
| Morgan Stanley | 436,699 | 1.02% | $236.62M | +27,411 | 0.01% |
| Vestal Point Capital, LP | 435,000 | 1.01% | $235.70M | +360,000 | 5.51% |
| Northern Trust Corp | 430,844 | 1.00% | $233.44M | −5,722 | 0.03% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 878 | 42M | 97.4% | 107 / 317 | 331 / 70 | 5M | 4M |
| Q1 2026 | 854 | 42M | 96.8% | 114 / 301 | 322 / 86 | 8M | 4M |
| Q4 2025 | 837 | 42M | 98.3% | 201 / 281 | 259 / 54 | 7M | 5M |
| Q3 2025 | 708 | 41M | 96.1% | 112 / 212 | 286 / 66 | 5M | 7M |
| Q2 2025 | 671 | 44M | 100.0% | 77 / 283 | 220 / 71 | 4M | 5M |
| Q1 2025 | 672 | 45M | 100.0% | 91 / 255 | 229 / 81 | 4M | 3M |
| Q4 2024 | 673 | 44M | 100.0% | 104 / 269 | 211 / 45 | 3M | 3M |
| Q3 2024 | 626 | 44M | 100.0% | 112 / 205 | 228 / 48 | 9M | 5M |
| Q2 2024 | 568 | 46M | 100.0% | 105 / 200 | 195 / 55 | 6M | 6M |
| Q1 2024 | 524 | 47M | 100.0% | 55 / 214 | 182 / 61 | 6M | 5M |
| Q4 2023 | 535 | 45M | 100.0% | 78 / 202 | 169 / 41 | 4M | 3M |
| Q3 2023 | 508 | 45M | 100.0% | 72 / 174 | 180 / 34 | 2M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of UTHR | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 1,452,598 | 3.39% | $787.06M | 0.63% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 1,347,720 | 3.14% | $730.24M | 0.03% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 973,490 | 2.27% | $527.47M | 0.28% | Jun 30, 2026 |
| Vanguard Health Care Fund | 719,385 | 1.68% | $372.43M | 0.98% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 486,555 | 1.13% | $263.63M | 0.27% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 308,328 | 0.72% | $167.06M | 0.25% | Jun 30, 2026 |
| Vanguard U.S. Growth Fund | 304,130 | 0.71% | $169.35M | 0.36% | May 31, 2026 |
| iShares Biotechnology ETF | 290,800 | 0.68% | $157.56M | 1.73% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 280,758 | 0.65% | $152.12M | 0.32% | Jun 30, 2026 |
| Invesco S&P MidCap Quality ETF | 266,163 | 0.62% | $137.80M | 2.53% | Jul 31, 2026 |
| iShares S&P Mid-Cap 400 Growth ETF | 253,957 | 0.59% | $137.60M | 1.22% | Jun 30, 2026 |
| Franklin Dynatech Fund | 225,000 | 0.52% | $121.91M | 0.40% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 221,883 | 0.52% | $123.55M | 0.29% | May 31, 2026 |
| State Street(R) SPDR(R) Portfolio S&P 400(TM) Mid Cap ETF | 214,879 | 0.50% | $116.43M | 0.63% | Jun 30, 2026 |
| Fullerthaler Behavioral Small Cap Equity | 204,471 | 0.48% | $110.79M | 0.88% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Martine A. Rothblatt | Chairperson & CEO, Director | 376,038 | 0.88% | Sep 30, 2026 |
| Paul A. Mahon | EVP & GENERAL COUNSEL | 45,172 | 0.11% | Sep 18, 2026 |
| James Edgemond | CFO AND TREASURER | 25,506 | 0.06% | Jun 23, 2026 |
| Michael Benkowitz | PRESIDENT AND COO | 36,462 | 0.09% | May 14, 2026 |
| Nilda Mesa | Director | 5,580 | 0.01% | Sep 15, 2026 |
| Ray Kurzweil | Director | 13,320 | 0.03% | Jul 23, 2026 |
| Tommy G. Thompson | Director | 22,480 | 0.05% | Jul 23, 2026 |
| Judy D. Olian | Director | 5,555 | 0.01% | Jul 23, 2026 |
| Kevin Tracey | Director | – | – | Jul 23, 2026 |
| Jan Malcolm | Director | 450 | 0.00% | Jul 23, 2026 |
| Linda Maxwell | Director | 2,000 | 0.00% | Jul 23, 2026 |
| Christopher Patusky | Director | 3,510 | 0.01% | Jul 23, 2026 |
| Christopher Causey | Director | 4,190 | 0.01% | Jul 23, 2026 |
| Louis W. Sullivan | Director | 4,440 | 0.01% | Jul 23, 2026 |
| Victor J. Dzau | Director | – | – | Jul 23, 2026 |
| Richard Giltner | Director | 21,884 | 0.05% | Jul 23, 2026 |
| Raymond Dwek | Director | 4,750 | 0.01% | Jul 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −2,309 | $478.10 | $1.10M | 326,623 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −1,200 | $479.07 | $574.88K | 325,423 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −500 | $481.22 | $240.61K | 324,763 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −2,135 | $477.09 | $1.02M | 328,932 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −1,395 | $476.10 | $664.16K | 331,067 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −552 | $475.12 | $262.27K | 332,462 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −80 | $473.86 | $37.91K | 333,014 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −449 | $472.97 | $212.36K | 333,094 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −400 | $472.05 | $188.82K | 333,543 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Option exercise | +9,500 | $117.76 | $1.12M | 333,943 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −200 | $486.77 | $97.35K | 324,443 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −120 | $482.28 | $57.87K | 324,643 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 29, 2026 | Sale(10b5-1 plan) | −160 | $479.59 | $76.73K | 325,263 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −160 | $476.68 | $76.27K | 332,143 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −80 | $475.28 | $38.02K | 332,303 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −680 | $474.46 | $322.63K | 332,383 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −600 | $473.28 | $283.97K | 333,063 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −280 | $472.43 | $132.28K | 333,663 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Option exercise | +9,500 | $117.76 | $1.12M | 333,943 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −160 | $486.01 | $77.76K | 324,443 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −1,315 | $485.45 | $638.37K | 324,603 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −825 | $484.47 | $399.69K | 325,918 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −1,539 | $483.20 | $743.64K | 326,743 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −693 | $482.11 | $334.10K | 328,282 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −1,354 | $481.20 | $651.54K | 328,975 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −1,013 | $480.18 | $486.42K | 330,329 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −601 | $479.06 | $287.92K | 331,342 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 28, 2026 | Sale(10b5-1 plan) | −200 | $477.45 | $95.49K | 331,943 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 25, 2026 | Sale(10b5-1 plan) | −2,744 | $476.13 | $1.31M | 328,003 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 25, 2026 | Sale(10b5-1 plan) | −1,280 | $477.19 | $610.80K | 326,723 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 25, 2026 | Option exercise | +9,500 | $117.76 | $1.12M | 333,943 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 25, 2026 | Sale(10b5-1 plan) | −40 | $470.56 | $18.82K | 333,903 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 25, 2026 | Sale(10b5-1 plan) | −632 | $478.95 | $302.70K | 324,443 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 25, 2026 | Sale(10b5-1 plan) | −1,613 | $475.28 | $766.63K | 330,747 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 25, 2026 | Sale(10b5-1 plan) | −543 | $474.15 | $257.46K | 332,360 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 25, 2026 | Sale(10b5-1 plan) | −800 | $472.89 | $378.31K | 332,903 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 25, 2026 | Sale(10b5-1 plan) | −200 | $471.84 | $94.37K | 333,703 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 25, 2026 | Sale(10b5-1 plan) | −1,648 | $478.18 | $788.04K | 325,075 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −40 | $480.33 | $19.21K | 324,443 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −600 | $479.52 | $287.71K | 324,483 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −1,480 | $478.61 | $708.34K | 325,083 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −2,160 | $471.77 | $1.02M | 328,540 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −280 | $476.51 | $133.42K | 326,923 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −320 | $475.35 | $152.11K | 327,203 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −437 | $474.01 | $207.14K | 327,523 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −580 | $472.73 | $274.18K | 327,960 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Option exercise | +9,500 | $117.76 | $1.12M | 333,943 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −640 | $469.74 | $300.63K | 333,303 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −2,603 | $470.63 | $1.23M | 330,700 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 24, 2026 | Sale(10b5-1 plan) | −360 | $477.58 | $171.93K | 326,563 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −90 | $498.90 | $44.90K | 324,683 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −480 | $492.54 | $236.42K | 326,649 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −240 | $500.05 | $120.01K | 324,443 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −160 | $493.72 | $79.00K | 326,489 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −155 | $495.17 | $76.75K | 326,334 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −525 | $496.38 | $260.60K | 325,809 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −766 | $497.27 | $380.91K | 325,043 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −270 | $498.38 | $134.56K | 324,773 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 23, 2026 | Option exercise | +9,500 | $117.76 | $1.12M | 333,943 |
| Martine A. Rothblatt Chairperson & CEO, Director | Sep 23, 2026 | Sale(10b5-1 plan) | −2,388 | $488.70 | $1.17M | 331,555 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Mahon Paul Officer | Oct 15, 2026 | 8,300 | $4.52M | Oct 15, 2026 | Stock Option Exercise |
| Rothblatt Martine Director, Officer | Oct 1, 2026 | 209,000 | $113.26M | Oct 1, 2026 | Exercise of Stock Options |
| Mahon Paul Officer | Oct 1, 2026 | 8,300 | $4.69M | Oct 1, 2026 | Stock Option Exercise |
| Mahon Paul Officer | Sep 17, 2026 | 8,300 | $4.13M | Sep 17, 2026 | Stock Option Exercise |
| Mesa Nilda Director | Sep 14, 2026 | 228 | $115.34K | Sep 14, 2026 | Stock Option Exercise |
| Mahon Paul Officer | Sep 3, 2026 | 8,300 | $4.00M | Sep 3, 2026 | Stock Option Exercise |
| Rothblatt Martine Officer | Sep 1, 2026 | 199,500 | $101.82M | Sep 1, 2026 | Exercise of Stock Options |
| Mahon Paul Officer | Aug 20, 2026 | 8,300 | $4.34M | Aug 20, 2026 | Stock Option Exercise |
| Mahon Paul Officer | Aug 6, 2026 | 8,300 | $4.29M | Aug 6, 2026 | Stock Option Exercise |
| Rothblatt Martine Director, Officer | Aug 3, 2026 | 199,500 | $103.28M | Aug 3, 2026 | Exercise of Stock Options |
| A. Mahon Paul Officer | Jul 16, 2026 | 8,300 | $4.43M | Jul 16, 2026 | Stock Option Exercise |
| Malcolm Jan Director | Jul 10, 2026 | 325 | $178.94K | Jul 10, 2026 | Restricted Stock |
| Mahon Paul Officer | Jul 2, 2026 | 8,300 | $4.59M | Jul 2, 2026 | Stock Option Exercise |
| Rothblatt Martine Director, Officer | Jul 1, 2026 | 209,000 | $113.24M | Jul 1, 2026 | Exercise of Stock Options |
| Mahon Paul Officer | Jun 18, 2026 | 8,300 | $4.49M | Jun 18, 2026 | Stock Option Exercise |